Table 1 The clinical characteristics of patients with GD and normal controls
From: The effect of radioiodine treatment on the characteristics of TRAb in Graves’ disease
Variable | Control group | Onset GD without 131I therapy | GD before 131I therapy | GD after 131I therapy | Normal range |
|---|---|---|---|---|---|
No. | 20 | 22 | 203 | ||
Age(y) | 42.20±15.87 | 40.09±13.71 | 43.98±12.39 | ||
Gender(M/F) | 11/9 | 3/19 | 31/172 | ||
FT3(pmol/L) | 4.70±1.39 | 21.17±9.62 | 20.77±8.85 | 4.46±1.32 | 3.5-6.5 |
FT4(pmol/L) | 14.69±4.44 | 64.48±44.15 | 56.77±34.57 | 15.27±7.47 | 11.5-22.7 |
TSH(mIU/L) | 3.19±3.09 | 0.002±0.001 | 0.09±0.75 | 12.95±24.65 | 0.55-4.78 |
TRAb(IU/L) | 0.65±0.48 | 11.28±10.17 | 16.95±12.47*** | 10.14±13.30 | 0-1.75 |
TPOAb(IU/mL) | 29.44±4.30 | 644.90±625.50 | 839.35±567.10### | 678.13±573.41 | 0-60 |